Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	226
Overall Study	STARTED	800 mg QD	216
Overall Study	STARTED	1200 mg QD	211
Overall Study	Safety Population	Placebo	224
Overall Study	Safety Population	800 mg QD	216
Overall Study	Safety Population	1200 mg QD	210
Overall Study	Intention-to-treat (ITT) Population	Placebo	220
Overall Study	Intention-to-treat (ITT) Population	800 mg QD	215
Overall Study	Intention-to-treat (ITT) Population	1200 mg QD	205
Overall Study	COMPLETED	Placebo	189
Overall Study	COMPLETED	800 mg QD	173
Overall Study	COMPLETED	1200 mg QD	142
Overall Study	NOT COMPLETED	Placebo	37
Overall Study	NOT COMPLETED	800 mg QD	43
Overall Study	NOT COMPLETED	1200 mg QD	69

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00988429/flow